Technical Analysis for PROG - Progenity, Inc.

Grade Last Price % Change Price Change
F 3.75 -3.10% -0.12
PROG closed down 3.1 percent on Monday, April 12, 2021, on 1.69 times normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Down Down
Historical PROG trend table...

Date Alert Name Type % Chg
Lower Bollinger Band Walk Weakness 0.00%
Wide Bands Range Expansion 0.00%
Below Lower BB Weakness 0.00%
Down 3 Days in a Row Weakness 0.00%
Down 4 Days in a Row Weakness 0.00%
Down 5 Days in a Row Weakness 0.00%
Lower Bollinger Band Touch Weakness 0.00%
Oversold Stochastic Weakness 0.00%
MACD Bearish Signal Line Cross Bearish -3.10%
Stochastic Reached Oversold Weakness -3.10%
Older End-of-Day Signals for PROG ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
1.5x Volume Pace about 3 hours ago
Down 3% about 3 hours ago
Rose Above Lower Bollinger Band about 6 hours ago
Down 2 % about 6 hours ago
Down 1% about 6 hours ago
View Earlier Intraday Alerts

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.


Progenity, Inc. Description

Progenity, Inc. is a biotechnology company with an established track record of success in developing and commercializing molecular testing products, as well as innovating in the field of precision medicine. Progenity provides in vitro molecular tests designed to improve lives by providing actionable information that helps guide patients and physicians in making medical decisions during key life stages. The company applies a multi-omics approach, combining genomics, epigenomics, proteomics, and metabolomics to its molecular testing products and to the development of a suite of investigational ingestible devices designed to provide precise diagnostic sampling and drug delivery solutions. Progenity’s vision is to transform healthcare to become more precise and personal by improving diagnoses of disease and improving patient outcomes through localized treatment with targeted therapies.


Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Biology Disease Genomics Drug Delivery In Vitro Precision Medicine Systems Biology Proteomics Systems Science

Is PROG a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength


Indicator Value
52 Week High 15.92
52 Week Low 3.08
Average Volume 436,112
200-Day Moving Average 6.80
50-Day Moving Average 5.11
20-Day Moving Average 4.52
10-Day Moving Average 4.44
Average True Range 0.42
ADX 20.92
+DI 15.53
-DI 31.71
Chandelier Exit (Long, 3 ATRs ) 3.88
Chandelier Exit (Short, 3 ATRs ) 4.97
Upper Bollinger Band 5.26
Lower Bollinger Band 3.79
Percent B (%b) -0.03
BandWidth 32.54
MACD Line -0.25
MACD Signal Line -0.20
MACD Histogram -0.0526
Fundamentals Value
Market Cap 176.16 Million
Num Shares 47 Million
EPS -0.99
Price-to-Earnings (P/E) Ratio -3.79
Price-to-Sales 1.91
Price-to-Book 0.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 4.17
Resistance 3 (R3) 4.21 4.10 4.10
Resistance 2 (R2) 4.10 4.00 4.09 4.08
Resistance 1 (R1) 3.93 3.93 3.88 3.89 4.05
Pivot Point 3.82 3.82 3.80 3.81 3.82
Support 1 (S1) 3.65 3.72 3.60 3.61 3.45
Support 2 (S2) 3.54 3.65 3.53 3.42
Support 3 (S3) 3.37 3.54 3.40
Support 4 (S4) 3.33